• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

端粒相关基因在多发性骨髓瘤中的表达谱。

Expression profile of telomere-associated genes in multiple myeloma.

机构信息

Andalusian Public Health System Biobank, Centro de Investigación Biomédica, Consejería de Salud-Universidad de Granada, Granada, Spain.

出版信息

J Cell Mol Med. 2012 Dec;16(12):3009-21. doi: 10.1111/j.1582-4934.2012.01628.x.

DOI:10.1111/j.1582-4934.2012.01628.x
PMID:22947336
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4393729/
Abstract

To further contribute to the understanding of multiple myeloma, we have focused our research interests on the mechanisms by which tumour plasma cells have a higher survival rate than normal plasma cells. In this article, we study the expression profile of genes involved in the regulation and protection of telomere length, telomerase activity and apoptosis in samples from patients with monoclonal gammopathy of undetermined significance, smouldering multiple myeloma, multiple myeloma (MM) and plasma cell leukaemia (PCL), as well as several human myeloma cell lines (HMCLs). Using conventional cytogenetic and fluorescence in situ hybridization studies, we identified a high number of telomeric associations (TAs). Moreover, telomere length measurements by terminal restriction fragment (TRF) assay showed a shorter mean TRF peak value, with a consistent correlation with the number of TAs. Using gene expression arrays and quantitative PCR we identified the hTERT gene together with 16 other genes directly involved in telomere length maintenance: HSPA9, KRAS, RB1, members of the Small nucleolar ribonucleoproteins family, A/B subfamily of ubiquitously expressed heterogeneous nuclear ribonucleoproteins, and 14-3-3 family. The expression levels of these genes were even higher than those in human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs), which have unlimited proliferation capacity. In conclusion, the gene signature suggests that MM tumour cells are able to maintain stable short telomere lengths without exceeding the short critical length, allowing cell divisions to continue. We propose that this could be a mechanism contributing to MM tumour cells expansion in the bone marrow (BM).

摘要

为了进一步深入了解多发性骨髓瘤,我们将研究兴趣集中在肿瘤浆细胞比正常浆细胞具有更高存活率的机制上。在本文中,我们研究了涉及端粒长度、端粒酶活性和凋亡调节和保护的基因在意义未明的单克隆丙种球蛋白血症、冒烟型多发性骨髓瘤、多发性骨髓瘤(MM)和浆细胞白血病(PCL)患者样本中的表达谱,以及几种人骨髓瘤细胞系(HMCLs)。通过常规细胞遗传学和荧光原位杂交研究,我们鉴定出大量的端粒相关(TA)。此外,通过末端限制性片段(TRF)分析测量端粒长度显示出较短的平均 TRF 峰值,与 TA 的数量呈一致的相关性。通过基因表达阵列和定量 PCR,我们鉴定了 hTERT 基因以及 16 个其他直接参与端粒长度维持的基因:HSPA9、KRAS、RB1、小核仁核糖核蛋白家族成员、广泛表达的异质核核糖核蛋白 A/B 亚家族,以及 14-3-3 家族。这些基因的表达水平甚至高于具有无限增殖能力的人类胚胎干细胞(hESCs)和诱导多能干细胞(iPSCs)。总之,该基因特征表明 MM 肿瘤细胞能够维持稳定的短端粒长度而不超过短临界长度,从而允许细胞分裂继续进行。我们提出,这可能是 MM 肿瘤细胞在骨髓(BM)中扩张的一种机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f01/4393729/3ad165e73854/jcmm0016-3009-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f01/4393729/f1d100cf2e84/jcmm0016-3009-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f01/4393729/2fdcb49c7d99/jcmm0016-3009-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f01/4393729/5e9cc63536cd/jcmm0016-3009-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f01/4393729/b6e213ae4ba3/jcmm0016-3009-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f01/4393729/ce74253645ed/jcmm0016-3009-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f01/4393729/cd6218c1066f/jcmm0016-3009-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f01/4393729/c196ad8e213b/jcmm0016-3009-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f01/4393729/3ad165e73854/jcmm0016-3009-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f01/4393729/f1d100cf2e84/jcmm0016-3009-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f01/4393729/2fdcb49c7d99/jcmm0016-3009-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f01/4393729/5e9cc63536cd/jcmm0016-3009-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f01/4393729/b6e213ae4ba3/jcmm0016-3009-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f01/4393729/ce74253645ed/jcmm0016-3009-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f01/4393729/cd6218c1066f/jcmm0016-3009-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f01/4393729/c196ad8e213b/jcmm0016-3009-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f01/4393729/3ad165e73854/jcmm0016-3009-f8.jpg

相似文献

1
Expression profile of telomere-associated genes in multiple myeloma.端粒相关基因在多发性骨髓瘤中的表达谱。
J Cell Mol Med. 2012 Dec;16(12):3009-21. doi: 10.1111/j.1582-4934.2012.01628.x.
2
Differential Expression of Non-Shelterin Genes Associated with High Telomerase Levels and Telomere Shortening in Plasma Cell Disorders.浆细胞疾病中与端粒酶水平升高和端粒缩短相关的非庇护蛋白基因的差异表达
PLoS One. 2015 Sep 14;10(9):e0137972. doi: 10.1371/journal.pone.0137972. eCollection 2015.
3
Molecular insights into the heterogeneity of telomere reprogramming in induced pluripotent stem cells.诱导多能干细胞中端粒重编程异质性的分子解析。
Cell Res. 2012 Apr;22(4):757-68. doi: 10.1038/cr.2011.201. Epub 2011 Dec 20.
4
Telomere shortening in patients with plasma cell disorders.浆细胞疾病患者的端粒缩短
Eur J Haematol. 2003 Nov;71(5):334-40. doi: 10.1034/j.1600-0609.2003.00157.x.
5
Altered mRNA expression of telomere-associated genes in monoclonal gammopathy of undetermined significance and multiple myeloma.意义未明的单克隆丙种球蛋白血症和多发性骨髓瘤中端粒相关基因的 mRNA 表达改变。
Mol Med. 2010 Nov-Dec;16(11-12):471-8. doi: 10.2119/molmed.2010.00057. Epub 2010 Jul 14.
6
DNA methylation mediated up-regulation of TERRA non-coding RNA is coincident with elongated telomeres in the human placenta.DNA甲基化介导的TERRA非编码RNA上调与人胎盘端粒延长同时发生。
Mol Hum Reprod. 2016 Nov;22(11):791-799. doi: 10.1093/molehr/gaw053. Epub 2016 Sep 7.
7
Decorin is down-regulated in multiple myeloma and MGUS bone marrow plasma and inhibits HGF-induced myeloma plasma cell viability and migration.核心蛋白聚糖在多发性骨髓瘤和意义未明的单克隆丙种球蛋白血症骨髓血浆中表达下调,并抑制 HGF 诱导的骨髓瘤浆细胞活力和迁移。
Eur J Haematol. 2013 Sep;91(3):196-200. doi: 10.1111/ejh.12125. Epub 2013 Jul 7.
8
Gene expression profiling of bone marrow endothelial cells in patients with multiple myeloma.多发性骨髓瘤患者骨髓内皮细胞的基因表达谱分析
Clin Cancer Res. 2009 Sep 1;15(17):5369-78. doi: 10.1158/1078-0432.CCR-09-0040. Epub 2009 Aug 18.
9
Telomere dynamics and homeostasis in a transmissible cancer.可传播癌症中的端粒动力学和动态平衡。
PLoS One. 2012;7(8):e44085. doi: 10.1371/journal.pone.0044085. Epub 2012 Aug 29.
10
Cytogenetic profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: a study in highly purified aberrant plasma cells.多发性骨髓瘤和意义未明的单克隆丙种球蛋白血症中的细胞遗传学特征:高度纯化的异常浆细胞研究。
Haematologica. 2013 Feb;98(2):279-87. doi: 10.3324/haematol.2011.060632. Epub 2012 Aug 28.

引用本文的文献

1
Versatility of 14-3-3 proteins and their roles in bone and joint-related diseases.14-3-3 蛋白的多功能性及其在骨骼和关节相关疾病中的作用。
Bone Res. 2024 Oct 15;12(1):58. doi: 10.1038/s41413-024-00370-4.
2
Prognostic significance of dysregulation of shelterin complex and its correlation with telomere length and cytogenetics in multiple myeloma.端粒保护蛋白复合体失调在多发性骨髓瘤中的预后意义及其与端粒长度和细胞遗传学的相关性
J Genet Eng Biotechnol. 2023 May 3;21(1):50. doi: 10.1186/s43141-023-00504-x.
3
Comprehensive characterization of the epigenetic landscape in Multiple Myeloma.

本文引用的文献

1
Telomeres and telomerase in human cancer (review).人类癌症中的端粒与端粒酶(综述)
Int J Oncol. 1995 Sep;7(3):423-32.
2
Pif1- and Exo1-dependent nucleases coordinate checkpoint activation following telomere uncapping.Pif1 和 Exo1 依赖性核酸酶在端粒解聚后协调检查点的激活。
EMBO J. 2010 Dec 1;29(23):4020-34. doi: 10.1038/emboj.2010.267. Epub 2010 Nov 2.
3
Telomerase inhibition targets clonogenic multiple myeloma cells through telomere length-dependent and independent mechanisms.端粒酶抑制通过端粒长度依赖和非依赖机制靶向克隆性骨髓瘤细胞。
全面描绘多发性骨髓瘤的表观遗传学特征。
Theranostics. 2022 Jan 16;12(4):1715-1729. doi: 10.7150/thno.54453. eCollection 2022.
4
Epigenetic Deregulation of Telomere-Related Genes in Newly Diagnosed Multiple Myeloma Patients.新诊断的多发性骨髓瘤患者中端粒相关基因的表观遗传失调
Cancers (Basel). 2021 Dec 17;13(24):6348. doi: 10.3390/cancers13246348.
5
Genome Instability in Multiple Myeloma: Facts and Factors.多发性骨髓瘤中的基因组不稳定:事实与因素
Cancers (Basel). 2021 Nov 26;13(23):5949. doi: 10.3390/cancers13235949.
6
Similarities and Differences of Hsp70, hsc70, Grp78 and Mortalin as Cancer Biomarkers and Drug Targets.热休克蛋白 70、热休克蛋白 70 同源物、葡萄糖调节蛋白 78 和线粒体蛋白作为癌症生物标志物和药物靶点的异同。
Cells. 2021 Nov 3;10(11):2996. doi: 10.3390/cells10112996.
7
YWHAE/14-3-3ε expression impacts the protein load, contributing to proteasome inhibitor sensitivity in multiple myeloma.YWHAE/14-3-3ε 的表达影响蛋白负荷,从而影响多发性骨髓瘤对蛋白酶体抑制剂的敏感性。
Blood. 2020 Jul 23;136(4):468-479. doi: 10.1182/blood.2019004147.
8
Dysregulation of H/ACA ribonucleoprotein components in chronic lymphocytic leukemia.慢性淋巴细胞白血病中H/ACA核糖核蛋白成分的失调
PLoS One. 2017 Jun 30;12(6):e0179883. doi: 10.1371/journal.pone.0179883. eCollection 2017.
9
Differential Expression of Non-Shelterin Genes Associated with High Telomerase Levels and Telomere Shortening in Plasma Cell Disorders.浆细胞疾病中与端粒酶水平升高和端粒缩短相关的非庇护蛋白基因的差异表达
PLoS One. 2015 Sep 14;10(9):e0137972. doi: 10.1371/journal.pone.0137972. eCollection 2015.
10
Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms.多发性骨髓瘤中的耐药性:分子机制的最新发现与新概念
Oncotarget. 2013 Dec;4(12):2186-207. doi: 10.18632/oncotarget.1497.
PLoS One. 2010 Sep 1;5(9):e12487. doi: 10.1371/journal.pone.0012487.
4
Altered mRNA expression of telomere-associated genes in monoclonal gammopathy of undetermined significance and multiple myeloma.意义未明的单克隆丙种球蛋白血症和多发性骨髓瘤中端粒相关基因的 mRNA 表达改变。
Mol Med. 2010 Nov-Dec;16(11-12):471-8. doi: 10.2119/molmed.2010.00057. Epub 2010 Jul 14.
5
Homozygous deletion mapping in myeloma samples identifies genes and an expression signature relevant to pathogenesis and outcome.在骨髓瘤样本中进行纯合缺失作图,可鉴定出与发病机制和预后相关的基因和表达特征。
Clin Cancer Res. 2010 Mar 15;16(6):1856-64. doi: 10.1158/1078-0432.CCR-09-2831. Epub 2010 Mar 9.
6
Effects of dyskeratosis congenita mutations in dyskerin, NHP2 and NOP10 on assembly of H/ACA pre-RNPs.先天性角化不良突变对核仁素、NHP2 和 NOP10 组装 H/ACA 前 RNP 的影响。
Hum Mol Genet. 2010 Mar 1;19(5):825-36. doi: 10.1093/hmg/ddp551. Epub 2009 Dec 15.
7
Kinome-wide RNAi studies in human multiple myeloma identify vulnerable kinase targets, including a lymphoid-restricted kinase, GRK6.在人类多发性骨髓瘤的全激酶 RNAi 研究中,确定了易受攻击的激酶靶标,包括淋巴样限制性激酶 GRK6。
Blood. 2010 Feb 25;115(8):1594-604. doi: 10.1182/blood-2009-09-243980. Epub 2009 Dec 7.
8
DKC1 overexpression associated with prostate cancer progression.DKC1过表达与前列腺癌进展相关。
Br J Cancer. 2009 Oct 20;101(8):1410-6. doi: 10.1038/sj.bjc.6605299. Epub 2009 Sep 15.
9
Analysis of telomere length in mantle cell lymphoma.套细胞淋巴瘤中端粒长度的分析
Eur J Haematol. 2009 Nov;83(5):433-8. doi: 10.1111/j.1600-0609.2009.01313.x. Epub 2009 Jul 6.
10
Telomere length as a biological marker in malignancy.端粒长度作为恶性肿瘤的生物学标志物。
Biochim Biophys Acta. 2009 Apr;1792(4):317-23. doi: 10.1016/j.bbadis.2009.01.017. Epub 2009 Feb 7.